Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, Inc. (“Catalent”) announced today that it has extended its offer to exchange up to $350,000,000 aggregate principal amount of its 7.875% Senior Notes due 2018 and the guarantees thereof, which have been registered under the Securities Act of 1933, as amended, for any and all of its outstanding 7.875% Senior Notes due 2018 and the guarantees thereof (the “Notes”), respectively, to 5:00 p.m., New York City time, on Monday, July 29, 2013, unless further extended.
Help employers find you! Check out all the jobs and post your resume.
